These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 15359836
1. [Quantification of hepatitis C virus RNA in serum]. Kawai S, Yokosuka O. Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):426-9. PubMed ID: 15359836 [No Abstract] [Full Text] [Related]
2. Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009. Gelderblom HC, Beld MG. J Clin Virol; 2010 Jun; 48(2):150-1; author reply 152. PubMed ID: 20347385 [No Abstract] [Full Text] [Related]
3. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases]. Serfaty L. Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289 [No Abstract] [Full Text] [Related]
4. [Clinical significance of measuring HCV-RNA levels in patients with chronic hepatitis C by IFN treatment, including combination therapy with ribavirin]. Kakumu S. Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):507-10. PubMed ID: 15359851 [No Abstract] [Full Text] [Related]
6. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level. Kawai S, Yokosuka O, Imazeki F, Saisho H, Mizuno C. J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820 [Abstract] [Full Text] [Related]
7. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C. De Mitri MS, Morsica G, Chen CH, Mele L, Baccarini P, Chianese R, Piccinini A, Lazzarin A, Pisi E. Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218 [Abstract] [Full Text] [Related]
9. [Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy]. Takenokuchi M, Yasuda C, Nakamachi Y, Mukai M, Yoon S, Kondoh S, Kumagai S. Rinsho Byori; 2002 Apr; 50(4):392-7. PubMed ID: 12014019 [Abstract] [Full Text] [Related]
11. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T. Hepatology; 2005 Jan; 41(1):106-14. PubMed ID: 15619235 [Abstract] [Full Text] [Related]
12. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. Comanor L, Anderson F, Ghany M, Perrillo R, Heathcote EJ, Sherlock C, Zitron I, Hendricks D, Gordon SC. Am J Gastroenterol; 2001 Oct; 96(10):2968-72. PubMed ID: 11693334 [Abstract] [Full Text] [Related]
13. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C. Naito M, Matsui A, Inao M, Nagoshi S, Nagano M, Ito N, Egashira T, Hashimoto M, Mishiro S, Mochida S, Fujiwara K. J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370 [Abstract] [Full Text] [Related]
14. [Treatment of chronic hepatitis C and alcohol consumption]. Mathurin P, Canva V, Dharancy S, Paris JC. Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B248-51. PubMed ID: 12180297 [No Abstract] [Full Text] [Related]
15. [Genetic diagnosis of hepatitis B and C]. Gervain J. Orv Hetil; 2003 Dec 28; 144(52):2547-52. PubMed ID: 15005063 [Abstract] [Full Text] [Related]